BUYSE, Marc

Email Alert RSS Feed

Profile

Full Name
BUYSE, Marc
Email
marc.buyse@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 61-80 of 218 (Search time: 0.004 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
612018Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better?Saad, Everardo D.; Zalcberg, John R.; Peron, Julien; Coart, Elisabeth; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
622018The search for surrogate endpoints for immunotherapy trialsBUYSE, Marc; BURZYKOWSKI, Tomasz; Saad, Everardo D.Journal ContributionA2
632017The potential and perils of observational studiesBUYSE, Marc; Vansteelandt, StijnJournal ContributionA1
642017Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapySaad, Everardo D.; BUYSE, MarcJournal ContributionA2
652017The impact of data errors on the outcome of randomized clinical trialsBUYSE, Marc; Squifflet, Pierre; Coart, Elisabeth; Quinaux, Emmanuel; Punt, Cornelis J. A.; Saad, Everardo D.Journal ContributionA1
662017Authors' Reply to Schoenfeld: "Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors"Michiels, Stefan; Saad, Everardo D.; BUYSE, MarcJournal ContributionA1
672017Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid TumorsMichiels, Stefan; Saad, Everardo D.; BUYSE, MarcJournal ContributionA1
82017Improving public health by improving clinical trial guidelines and their applicationLandray, Martin J.; Bax, Jeroen J.; Alliot, Laurence; BUYSE, Marc; Cohen, Adam; Collins, Rory; Hindricks, Gerhard; James, Stefan K.; Lane, Sile; Maggioni, Aldo P.; Meeker-O'Connell, Ann; Olsson, Gunnar; Pocock, Stuart J.; Rawlins, Michael; Sellors, Jonathan; Shinagawa, Kaori; Sipido, Karin R.; Smeeth, Liam; Stephens, Richard; Stewart, Murray W.; Stough, Wendy Gattis; Sweeney, Fergus; Van de Werf, Frans; Woods, Kerrie; Casadei, BarbaraJournal ContributionA1
92017Adoption of Pathologic Complete Response as a Surrogate End Point in Neoadjuvant Trials in HER2-Positive Breast Cancer Still an Open QuestionBURZYKOWSKI, Tomasz; Saad, Everardo D.; BUYSE, MarcJournal ContributionA1
102017Use of the Beta-Binomial Model for Central Statistical Monitoring of Multicenter Clinical TrialsDesmet, Lieven; Venet, David; Doffagne, Erik; Timmermans, Catherine; LEGRAND, Catherine; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
112017Precision medicine needs randomized clinical trialsSaad, Everardo D.; PAOLETTI, Xavier; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
122017Evaluation of failure time surrogate endpoints in individual patient data meta-analyses of randomized clinical trials. A poisson approachRotolo, Federico; PAOLETTI, Xavier; BURZYKOWSKI, Tomasz; BUYSE, Marc; Michiels, StefanJournal ContributionM
132017Applied Surrogate Endpoint Evaluation Methods with SAS and RALONSO ABAD, Ariel; BIGIRUMURAME, Theophile; BURZYKOWSKI, Tomasz; BUYSE, Marc; MOLENBERGHS, Geert; MUCHENE, Leacky; PERUALILA, Nolen Joy; SHKEDY, Ziv; VAN DER ELST, WimBookB1
142016Data Sharing - Is the Juice Worth the Squeeze?Strom, Brian L.; BUYSE, Marc; Hughes, John; Knoppers, Bartha M.Journal ContributionA1
152016Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancerMichiels, Stefan; Pugliano, L.; Marguet, S.; Grun, D.; Barinoff, J.; Cameron, D.; Cobleigh, M.; Di Leo, A.; Johnston, S.; Gasparini, G.; Kaufman, B.; Marty, M.; Nekljudova, V.; Paluch-Shimon, S.; Penault-Llorca, F.; Slamon, D.; Vogel, C.; von Minckwitz, G.; BUYSE, Marc; Piccart, M.Journal ContributionA1
162016The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical TrialsPeron, Julien; Roy, Pascal; Ozenne, Brice; Roche, Laurent; BUYSE, MarcJournal ContributionA1
172016Fraud in clinical trials: complex problem, simple solutions?Sakamoto, Junichi; BUYSE, MarcJournal ContributionA2
182016Statistical controversies in clinical research: end points other than overall survival are vital for regulatory approval of anticancer agentsSaad, E. D.; BUYSE, MarcJournal ContributionA1
192016Response to the letter to the editor 'Reply to "Statistical controversies in clinical research: end points other than survival are vital for regulatory approval of anticancer agents" by H. K. van Halteren'Saad, E. D.; BUYSE, MarcJournal ContributionA1
202016Neratinib after trastuzumab in patients with HER2-positive breast cancer ReplyChan, Arlene; BUYSE, Marc; Yao, BinJournal ContributionA1
show all